AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,448,000 | -38.5% | 279,599 | +13.1% | 0.00% | – |
| Q4 2015 | $2,355,000 | +22.5% | 247,194 | +6.0% | 0.00% | – |
| Q3 2015 | $1,923,000 | -43.6% | 233,153 | +11.1% | 0.00% | – |
| Q2 2015 | $3,408,000 | -17.0% | 209,906 | +107.0% | 0.00% | – |
| Q1 2015 | $4,108,000 | -6.3% | 101,411 | +24.9% | 0.00% | – |
| Q4 2014 | $4,386,000 | +126.1% | 81,208 | +43.0% | 0.00% | – |
| Q3 2014 | $1,940,000 | – | 56,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|